Partner Content Partner Content Fishawack Health acquires HEOR consultancy PAI Fishawack Health expands its VEA capabilities
Views & Analysis 2021 market access prospects for Spain 2021 will be the year when big market access changes – including the far wider use of health economic evaluation – are implemented in Spain.
Views & Analysis Web and mobile technologies for health economics modelling Digital apps are more agile than longstanding solutions and allow tailored interrogation of data.
Articles Does real world evidence matter in Health Technology Assessm... Health Technology Assessment (HTA) agencies usually rely on randomised controlled trials for clinical data when evaluating drugs, but these do not always tell the entire story.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
